News
AVTR
9.09
-5.76%
-0.56
Avantor Price Target Cut to $9.00/Share From $12.00 by Barclays
Dow Jones · 6h ago
Avantor Is Maintained at Equal-Weight by Barclays
Dow Jones · 6h ago
Barclays Maintains Equal-Weight on Avantor, Lowers Price Target to $9
Benzinga · 7h ago
Avantor price target lowered to $10.50 from $13 at UBS
TipRanks · 7h ago
Avantor price target lowered to $10 from $12 at TD Cowen
TipRanks · 8h ago
Avantor price target lowered to $10 from $12 at Stifel
TipRanks · 8h ago
Avantor price target lowered to $8 from $9 at Jefferies
TipRanks · 8h ago
Avantor price target lowered to $9 from $12 at Barclays
TipRanks · 8h ago
Avantor price target lowered to $11 from $15 at Baird
TipRanks · 9h ago
Analysts Offer Insights on Healthcare Companies: Humana (HUM), Inspire Medical Systems (INSP) and Avantor (AVTR)
TipRanks · 9h ago
Barclays Keeps Their Hold Rating on Avantor (AVTR)
TipRanks · 9h ago
Analysts Offer Insights on Healthcare Companies: Avantor (AVTR), Novo Nordisk (NVO) and Neurocrine (NBIX)
TipRanks · 10h ago
Avantor (AVTR) Q3 Loss Of US$711.8 Million Tests Bullish Earnings Narratives
Simply Wall St · 14h ago
Avantor: Elevated Execution Risk and Limited Visibility Justify Hold and Wait‑and‑See Stance
TipRanks · 17h ago
Avantor Earnings Call: Strategy Advances, Profits Squeezed
TipRanks · 21h ago
Avantor: Subdued Outlook and Execution Risks Justify Hold Rating and Trimmed Target Price
TipRanks · 1d ago
Software Slump Resumes, Bitcoin Plunges To 66,000: What's Moving Markets Wednesday?
Benzinga · 1d ago
Avantor price target lowered to $11 from $13 at BofA
TipRanks · 1d ago
Avantor price target lowered to $11 from $13 at Citi
TipRanks · 1d ago
Avantor Falls To Critical Levels As CEO Signals Investment Year Amid Soft Guidance
Benzinga · 1d ago
More
Webull provides a variety of real-time AVTR stock news. You can receive the latest news about Avantor through multiple platforms. This information may help you make smarter investment decisions.
About AVTR
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.